Skip to main content
Premium Trial:

Request an Annual Quote

DiagnoCure Board Votes to Liquidate, Dissolve Company

NEW YORK (GenomeWeb) – Canadian life sciences firm DiagnoCure announced today that its board has approved a plan to voluntarily dissolve the company and liquidate its assets.

"The board of directors of DiagnoCure has determined that the liquidation and dissolution is advisable and in the best interest of the corporation and its shareholders," DiagnoCure Chairman Jacques Simoneau said in a statement.

A special meeting will be held on May 19 to submit the plan to shareholders for their approval. If the plan is approved, PricewaterhouseCoopers will be appointed liquidator. DiagnoCure also said it will submit an application to have its shares delisted from the Toronto Stock Exchange.

In December, DiagnoCure sold its PCA3 prostate cancer biomarker and related assets to Hologic subsidiary Gen-Probe. Simoneau said that the company had been in discussions to sell other assets related to its multi-marker prostate cancer test and its Previstage GCC colorectal cancer test, but these failed to result in formal offers.

"Given the limited financial resources remaining after the distribution to the shareholders of substantially all the proceeds from the PCA3 asset sale transaction, the corporation has decided to initiate a liquidation and dissolution process," Simoneau added.

Earlier this year, DiagnoCure reported finishing 2015 with C$1.1 million in cash and short-term investments amid swelling losses and dropping revenues.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.